Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Toronto
$5,000.00
Biomaterial stiffness regulation of mesenchymal stem cell osteogenic and myofibrogenic differentiation
FY 2013-14
Summary
Musculoskeletal diseases are one of the most significant economic and health burdens in Canada. A candidate approach to regenerate or replace diseased or damaged tissue is to use adult mesenchymal stem cells (MSCs) delivered to the repair site with a biomaterial. Besides housing the MSCs, the biomaterial's mechanical stiffness has also shown substantial impact on the ability of the MSCs to mature into functional cells, such as those that make bone and connective tissues. If we can understand and harness this phenomenon, we should be able to design better biomaterials for the regeneration of skeletal tissues.
Based on preliminary work in our lab, we hypothesize that a molecule called FHL2 is required for a biomaterial's stiffness to direct bone and connective tissue formation by MSCs. In this summer research project, an undergraduate researcher will test this hypothesis. Using genetics and drugs, she will manipulate FHL2 levels in human MSCs grown in the lab and then test whether they can become specialized bone or connective tissue cells on biomaterials with different mechanical stiffnesses. We expect that FHL2 will be required for MSCs to become specialized cells on different biomaterials. We hope to unveil some underlying molecular mechanisms that will help guide biomaterial design for MSC-based tissue regeneration. Contributions in the long term may include uncovering novel strategies for bone and connective tissue regeneration by modulating FHL2 activity using drugs or customized biomaterials.
More immediately, this project will further the career of a promising young scientist in regenerative medicine and musculoskeletal health research and train her in an interdisciplinary research environment with a track record of success in training new scientists. By equipping and encouraging her to pursue this field, our goal is that she will contribute to advances in health technology in the future to improve the health of Canadians.
Department
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
303311
Name
Ngai Jessica
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Biomaterial stiffness regulation of mesenchymal stem cell osteogenic and myofibrogenic differentiation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Biomaterials; Biomechanics; Myofibrogenesis; Osteogenesis; Stem Cells
Abstract
Musculoskeletal diseases are one of the most significant economic and health burdens in Canada. A candidate approach to regenerate or replace diseased or damaged tissue is to use adult mesenchymal stem cells (MSCs) delivered to the repair site with a biomaterial. Besides housing the MSCs, the biomaterial's mechanical stiffness has also shown substantial impact on the ability of the MSCs to mature into functional cells, such as those that make bone and connective tissues. If we can understand and harness this phenomenon, we should be able to design better biomaterials for the regeneration of skeletal tissues.
Based on preliminary work in our lab, we hypothesize that a molecule called FHL2 is required for a biomaterial's stiffness to direct bone and connective tissue formation by MSCs. In this summer research project, an undergraduate researcher will test this hypothesis. Using genetics and drugs, she will manipulate FHL2 levels in human MSCs grown in the lab and then test whether they can become specialized bone or connective tissue cells on biomaterials with different mechanical stiffnesses. We expect that FHL2 will be required for MSCs to become specialized cells on different biomaterials. We hope to unveil some underlying molecular mechanisms that will help guide biomaterial design for MSC-based tissue regeneration. Contributions in the long term may include uncovering novel strategies for bone and connective tissue regeneration by modulating FHL2 activity using drugs or customized biomaterials.
More immediately, this project will further the career of a promising young scientist in regenerative medicine and musculoskeletal health research and train her in an interdisciplinary research environment with a track record of success in training new scientists. By equipping and encouraging her to pursue this field, our goal is that she will contribute to advances in health technology in the future to improve the health of Canadians.
Competitiondate
201401
Approvedterm2
0 yr 3 mths
Pinamesdelim
Ngai, Jessica
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $5,000~ $0~